Virus Genes

, Volume 42, Issue 1, pp 1–8 | Cite as

Influenza A viruses: why focusing on M2e-based universal vaccines

Article

Abstract

The threat of highly virulent avian influenza, such as H5N1 and swine-origin H1N1 influenza viruses, bring out an urgent need to develop a universal influenza vaccine, which may provide cross-protection against different strain of influenza A viruses. The extra-domain of influenza M2 protein (M2e), which is almost completely conserved among all subtypes of influenza A viruses, is considered as a promising candidate target for the development of a broad-spectrum recombinant influenza A vaccine. The results of several preclinical studies with M2e protein, with or without carriers, have already proved the successful protection of M2e-based vaccinated animal model against lethal challenge of heterologous and homologous influenza A viruses. Recently, the results of Phase I/II clinical trail studies with M2e-based vaccines have raised hopes for considering these vaccines against seasonal and pandemic influenza A strains. Hence, it is expected that more and more effective and safe universal influenza vaccines based on M2e will be developed for prevention of seasonal and pandemic influenza in the near future.

Keywords

Influenza virus M2e protein Universal vaccine 

References

  1. 1.
    D.M. Morens, G.K. Folkers, A.S. Fauci, Nature 430, 242–249 (2004)PubMedCrossRefGoogle Scholar
  2. 2.
    T. Horimoto, Y. Kawaoka, Nat. Rev. Microbiol. 3, 591–600 (2005)PubMedCrossRefGoogle Scholar
  3. 3.
    B.C. Buxton, J.M. Katz, W.H. Seto, P.K. Chan, D. Tsang, W. Ho, K.H. Mak, W. Lim, J.S. Tam, M. Clarke, J. Infect. Dis. 181, 344–348 (2000)CrossRefGoogle Scholar
  4. 4.
    M. Peiris, K.Y. Yuen, C.W. Leung, K.H. Chan, P.L. Ip, R.W. Lai, W.K. Orr, K.F. Shortridge, Lancet 354, 916–917 (1999)PubMedCrossRefGoogle Scholar
  5. 5.
    R.J. Garten, C.T. Davis, C.A. Russell, B. Shu, S. Lindstrom, A. Balish, W.M. Sessions, X. Xu, E. Skepner, V. Deyde, Science 325, 197–201 (2009)PubMedCrossRefGoogle Scholar
  6. 6.
    G. Neumann, T. Noda, Y. Kawaoka, Nature 459, 931–939 (2009)PubMedCrossRefGoogle Scholar
  7. 7.
    W. Fiers, M.D. Filette, A. Birket, S. Neirynck, W.M. Jou, Virus Res. 103, 173–176 (2004)PubMedCrossRefGoogle Scholar
  8. 8.
    P.F. Wright, R.G. Webster, in Fields Virology, ed. by D.M. Knipe, P.M. Howley (Lippincott Williams & Wilkins, Philadelphia, 2001), pp. 1533–1579Google Scholar
  9. 9.
    R.A. Fouchier, V. Munster, A. Wallensten, T.M. Bestebroer, S. Herfst, D. Smith, G.F. Rimmelzwaan, B. Olsen, A.D. Osterhaus, J. Virol. 79, 2814–2822 (2005)PubMedCrossRefGoogle Scholar
  10. 10.
    P.C. Crawford, E.J. Dubovi, W.L. Castleman et al., Science 310, 482–485 (2005)PubMedCrossRefGoogle Scholar
  11. 11.
    D.A. Steinhauer, J.J. Skehel, Genetics of influenza viruses. Ann. Rev. Genet. 36, 305–332 (2002)PubMedCrossRefGoogle Scholar
  12. 12.
    R.A. Lamb, R.M. Klug, in Fundamental Virology, ed. by B.N. Fields, D.M. Knipe, P.M. Howley (Lippincott-Raven, Philadelphia, 2006), pp. 605–647Google Scholar
  13. 13.
    W. Gerhard, K. Mozdzanowska, D. Zharikova, Emerg. Infect. Dis. 12, 569–574 (2006)PubMedGoogle Scholar
  14. 14.
    Influenza health topic. www.who.int/topics/influenza/en/
  15. 15.
    D.M. Skowronski, C. Masaro, T.L. Kwindt, A. Mak, M. Petric, Y. Li, Vaccine 25, 2842–2851 (2007)PubMedCrossRefGoogle Scholar
  16. 16.
    J.S. Oxford, C. Manuguerra, O. Kistner, A. Linde, M. Kunze, W. Lange, B. Schweiger, G. Spala, H.R. De Andrade, P.R. Perez Brena, Vaccine 23, 5440–5449 (2005)PubMedCrossRefGoogle Scholar
  17. 17.
    K.L. Nichol, J.J. Treanor, J. Infect. Dis. 194, 111–118 (2006)CrossRefGoogle Scholar
  18. 18.
    R. Belshe, M.S. Lee, R.E. Walker, J. Stoddard, P.M. Mendelman, Expert Rev. Vaccines 3, 643–654 (2004)PubMedCrossRefGoogle Scholar
  19. 19.
    L.G. Rudenko, N.I. Lonskaya, A.I. Klimov, R.I. Vasilieva, A. Ramirez, Bull. WHO 74, 77–78 (1996)PubMedGoogle Scholar
  20. 20.
    B.E. Johansson, I.C. Brett, Vaccine 25, 3062–3065 (2007)PubMedCrossRefGoogle Scholar
  21. 21.
    L. Widjaja, N. Ilyushina, R.G. Webster, R.J. Webby, Virology 350, 137–145 (2006)PubMedCrossRefGoogle Scholar
  22. 22.
    R.A. Lamb, C.J. Lai, P.W. Choppin, Proc. Natl. Acad. Sci. USA 78, 4170–4174 (1981)PubMedCrossRefGoogle Scholar
  23. 23.
    G.V. Heijne, EMBO J. 5, 3021–3027 (1986)PubMedGoogle Scholar
  24. 24.
    L.H. Pinto, L.J. Holsinger, R.A. Lamb, Cell 69, 517–528 (1992)PubMedCrossRefGoogle Scholar
  25. 25.
    I.V. Chizhmakov, F.M. Geraghty, D.C. Ogden, A. Hayhurst, M. Antoniou, A.J. Hay, J. Physiol. 494, 329–336 (1996)PubMedGoogle Scholar
  26. 26.
    J.A. Mould, J.E. Drury, S.M. Frings, U.B. Kaupp, A. Pekosz, R.A. Lamb, L.H. Pinto, J. Biol. Chem. 275, 31038–31050 (2000)PubMedCrossRefGoogle Scholar
  27. 27.
  28. 28.
    F. Ciampor, P.M. Bayley, M.V. Nermut, E.M. Hirst, R.J. Sugrue, A.J. Hay, Virology 188, 14–24 (1992)PubMedCrossRefGoogle Scholar
  29. 29.
    S. Grambas, A.J. Hay, Virology 190, 11–18 (1992)PubMedCrossRefGoogle Scholar
  30. 30.
    K. Iwatsuki-Horimoto, T. Horimoto, T. Noda, M. Kiso, J. Maeda, S. Watanabe, Y. Muramoto, K. Fujii, Y. Kawaoka, J. Virol. 80, 5233–5240 (2006)PubMedCrossRefGoogle Scholar
  31. 31.
    R.J. Sugrue, R.B. Belshe, A.J. Hay, Virology 179, 51–56 (1990)PubMedCrossRefGoogle Scholar
  32. 32.
    M.F. Mc Cown, A. Pekosz, J. Virol. 80, 8178–8189 (2006)CrossRefGoogle Scholar
  33. 33.
    L.J. Holsinger, M.A. Shaughnessy, A. Micko, J. Virol. 69, 1219–1225 (1995)PubMedGoogle Scholar
  34. 34.
    L.J. Holsinger, R.A. Lamb, Virology 183, 32–43 (1991)PubMedCrossRefGoogle Scholar
  35. 35.
    R.J. Sugrue, A.J. Hay, Virology 180, 617–624 (1991)PubMedCrossRefGoogle Scholar
  36. 36.
    R.A. Lamb, S.L. Zebedee, C.D. Richardson, Cell 40, 627–633 (1985)PubMedCrossRefGoogle Scholar
  37. 37.
    S.L. Zebedee, R.A. Lamb, J. Virol. 62, 2762–2772 (1988)PubMedGoogle Scholar
  38. 38.
    W. Liu, P. Zou, J. Ding, Y. Lu, Y.H. Chen, Microbes Infect. 7, 171–177 (2005)PubMedCrossRefGoogle Scholar
  39. 39.
    R.A. Black, P.A. Rota, N. Gorodkova, H.D. Klenk, A.P. Kendal, J. Gen. Virol. 74, 143–146 (1993)PubMedCrossRefGoogle Scholar
  40. 40.
    A. Jegerlehner, N. Schmitz, T. Storni, M.F. Bachmann, J. Immunol. 172, 5598–5605 (2004)PubMedGoogle Scholar
  41. 41.
    V.C. Huber, J.M. Lynch, D.J. Bucher, J. Le, D.W. Metzger, J. Immunol. 166, 7381–7388 (2001)PubMedGoogle Scholar
  42. 42.
    A.M. Eriksson, K.M. Schon, N.Y. Lycke, J. Immunol. 173, 3310–3319 (2004)PubMedGoogle Scholar
  43. 43.
    K. Mozdzanowska, K. Maiese, M. Furchner, W. Gerhard, Virology 254, 138–146 (1999)PubMedCrossRefGoogle Scholar
  44. 44.
    K. Subbarao, T. Joseph, Nat. Rev. Microbiol. 7, 267–278 (2007)CrossRefGoogle Scholar
  45. 45.
    F.M. De, W. Martens, K. Roose, T. Deroo, F. Vervalle, M. Bentahir, J. Vandekerckhove, W. Fiers, X. Saelens, J. Biol. Chem. 283, 11382–11387 (2008)CrossRefGoogle Scholar
  46. 46.
    M. De Filette, W. Martens, A. Smet, M. Schotsaert, A. Birkett, P. Londoño-Arcila, W. Fiers, X. Saelens, Vaccine 26, 6503–6507 (2008)PubMedCrossRefGoogle Scholar
  47. 47.
    S.M. Ebrahimi, M. Tebianian, Mol. Biol. Rep. 37, 2877–2883 (2010)PubMedCrossRefGoogle Scholar
  48. 48.
    S.M. Ebrahimi, M. Tebianian, H. Toghyani, A. Memarnejadian, H.R. Attaran, Protein Expr. Purif. 70, 7–12 (2010)PubMedCrossRefGoogle Scholar
  49. 49.
    J.W. Huleatt, V. Nakaar, P. Desai, Y. Huang, D. Hewitt, A. Jacobs, Vaccine 26, 201–214 (2008)PubMedCrossRefGoogle Scholar
  50. 50.
    J. Bessa, N. Schmitz, H.J. Hinton, K. Schwarz, A. Jegerlehner, M.F. Bachmann, Eur. J. Immunol. 38, 114–126 (2008)PubMedCrossRefGoogle Scholar
  51. 51.
    R.M. Ionescu, C.T. Przysiecki, X. Liang, V.M. Garsky, J. Fan, B. Wang, R. Troutman, Y. Rippeon, E. Flanagan, J. Shiver, J. Pharm. Sci. 95, 70–79 (2006)PubMedCrossRefGoogle Scholar
  52. 52.
    S.M. Tompkins, Z.S. Zhao, C.Y. Lo, J.A. Misplon, T. Liu, Z. Ye, R.J. Hogan, Z. Wu, K.A. Benton, T.M. Tumpey, S.L. Epstein, Emerg. Infect. Dis. 13, 426–435 (2007)PubMedCrossRefGoogle Scholar
  53. 53.
    W. Liu, H. Li, Y.H. Chen, F.E.M.S. Immunol, Med. Microbiol. 35, 141–146 (2003)Google Scholar
  54. 54.
    K. Mozdzanowska, J. Feng, M. Eid, G. Kragol, M. Cudic, L. Otvos, W. Gerhard, Vaccine 21, 2616–2626 (2003)PubMedCrossRefGoogle Scholar
  55. 55.
    W.A. Ernst, H.J. Kim, T.M. Tumpey, A.D. Jansen, W. Tai, D.V. Cramer, J.P. Adler-Moore, G. Fujii, Vaccine 24, 5158–5168 (2006)PubMedCrossRefGoogle Scholar
  56. 56.
    J. Fan, X. Liang, M.S. Horton, H.C. Perry, M.P. Citron, G.J. Heidecker, T.M. Fu, J. Joyce, C.T. Przysiecki, P.M. Keller, Vaccine 22, 2993–3003 (2004)PubMedCrossRefGoogle Scholar
  57. 57.
    A.M. Frace, A.I. Klimov, T. Rowe, R.A. Black, J.M. Katz, Vaccine 17, 2237–2244 (1999)PubMedCrossRefGoogle Scholar
  58. 58.
    W. Liu, Z. Peng, Z. Liu, Y. Lu, J. Ding, Y.H. Chen, Vaccine 23, 366–371 (2004)PubMedCrossRefGoogle Scholar
  59. 59.
    K. Mozdzanowska, M. Furchner, D. Zharikova, J. Feng, W. Gerhard, J. Virol. 79, 5943–5951 (2005)PubMedCrossRefGoogle Scholar
  60. 60.
    J.J. Treanor, E.L. Tierney, S.L. Zebedee, R.A. Lamb, B.R. Murphy, J. Virol. 64, 1375–1377 (1990)PubMedGoogle Scholar
  61. 61.
    V.A. Slepushkin, J.M. Katz, R.A. Black, W.C. Gamble, P.A. Rota, N.J. Cox, Vaccine 13, 1399–1402 (1995)PubMedCrossRefGoogle Scholar
  62. 62.
    G. Zhao, Y. Lin, L. Du, J. Guan, S. Sun, H. Sui, Virol. J. 7, 9 (2010)PubMedCrossRefGoogle Scholar
  63. 63.
    A.C. Tissot, R. Renhofa, N. Schmitz, I. Cielens, E. Meijerink, V. Ose, G.T. Jennings, P. Saudan, P. Pumpens, M.F. Bachmann, PLoS One 5, e9809 (2010)PubMedCrossRefGoogle Scholar
  64. 64.
    S. Neirynck, T. Deroo, X. Saelens, P. Vanlandschoot, W.M. Jou, W. Fiers, Nat. Med. 5, 1157–1163 (1999)PubMedCrossRefGoogle Scholar
  65. 65.
    M. De Filette, W. Min Jou, A. Birkett, K. Lyons, B. Schultz, A. Tonkyro, A. Resch, S. Fiers, Virology 337, 149–161 (2005)PubMedCrossRefGoogle Scholar
  66. 66.
    T.M. Fu, K.M. Grimm, M.P. Citron, D.C. Freed, J. Fan, P.M. Keller, J.W. Shiver, X. Liang, J.G. Joyce, Vaccine 27, 1440–1447 (2009)PubMedCrossRefGoogle Scholar
  67. 67.
    P.P. Heinen, F.A. Rijsewijk, E.A. De Boer-Luijtze, A.T. Bianchi, J. Gen. Virol. 83, 1851–1859 (2002)PubMedGoogle Scholar
  68. 68.
    P. Kitikoon, A.L. Vincent, B.H. Janke, B. Erickson, E.L. Strait, S. Yu, M.R. Gramer, E.L. Thacker, Vaccine 28, 523–531 (2010)CrossRefGoogle Scholar
  69. 69.
  70. 70.
    W. Fiers, M. De Filette, K.E. Bakkouri, B. Schepens, K. Roose, M. Schotsaert, A. Birkett, X. Saelens, Vaccine 27, 6280–6283 (2009)PubMedCrossRefGoogle Scholar
  71. 71.
  72. 72.
  73. 73.
  74. 74.
    M. Schotsaert, M. De Filette, W. Fiers, Vaccines 8, 499–508 (2009)CrossRefGoogle Scholar
  75. 75.
    S.M. Ebrahimi, M. Tebianian, K. Aghaiypour, H. Nili, A. Mirjalili, Mol. Biol. Rep. 37, 2909–2914 (2010)PubMedCrossRefGoogle Scholar
  76. 76.
    S.M. Ebrahimi, K. Aghaiypour, H. Nili, Iran J. Biotechnol. 6, 229–232 (2008)Google Scholar
  77. 77.
    S.M. Ebrahimi, M. Tebianian, A. Mirjalili, H. Paykari, H.R. Varshovi, H. Toghyani, S. Moradi Bidhendi, H.R. Attaran, Arch. Razi Ins. 64, 71–76 (2009)Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of BiotechnologyRazi Vaccine and Serum Research Institute (RVSRI)TehranIran

Personalised recommendations